_id
69148d06ccc777a4e85d9a63
Ticker
PHBBF
Name
Pharmaron Beijing Co., Ltd.
Exchange
PINK
Address
Building 1, Beijing, China, 100176
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.pharmaron.com
Description
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Production Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science and preformulation, formulation development, and analytical development. It also provides clinical research services; macromolecular and cell and gene therapy services comprising drug discovery, development and production services, cell and gene therapy laboratory services, and gene therapy drug development and production services. In addition, the company is involved in the provision of technology development, technology transfer, technical consultation, technical services, and technical training; import and export of goods and technologies. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
Last Close
1.93
Volume
-
Current Price
1.93
Change
0
Last Updated
2026-01-06T09:09:07.154Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
3431917312
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
3342137220.1
Cost Of Revenue
2197162276.43
Gross Profit
1144974943.67
Operating Expenses
2815775272.61
Operating Income
526361947.49
Interest Expense
50294751.61
Pretax Income
449168388.3
Net Income
395820648.68
Eps
0.22259680845839494
Dividends Per Share
45931616.8
Shares Outstanding
301537125
Income Tax Expense
-
EBITDA
-
Operating Margin
15.749262008884566
Total Other Income Expense Net
-
Cash
1301728328.16
Short Term Investments
859819591.42
Receivables
2544688491.63
Inventories
1305149095.05
Total Current Assets
7593140091.62
Property Plant Equipment
11166626715.47
Total Assets
25197008155.37
Payables
527832654.3
Short Term Debt
-
Long Term Debt
4209325766.81
Total Liabilities
10327954797.3
Equity
14265949611.81
Bs_currency_symbol
CNY
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
598427205.45
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
34493942.86
Cf_currency_symbol
CNY
PE
16.0833
PB
0.2405670464732963
ROE
2.774583252083841
ROA
1.5709033637616319
FCF
-
Fcf Percent
-
Piotroski FScore
2
Health Score
56
Deep Value Investing Score
6
Defensive Investing Score
7.5
Dividend Investing Score
2
Economic Moat Investing Score
5.8
Garp Investing Score
5
Growth Investing Score
3.5
Momentum Investing Score
4
Net Net Investing Score
3
Quality Investing Score
5
Value Investing Score
8
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
3342137220.1
Quarters > 0 > income Statement > cost Of Revenue
2197162276.43
Quarters > 0 > income Statement > gross Profit
1144974943.67
Quarters > 0 > income Statement > operating Expenses
2815775272.61
Quarters > 0 > income Statement > operating Income
526361947.49
Quarters > 0 > income Statement > interest Expense
50294751.61
Quarters > 0 > income Statement > pretax Income
449168388.3
Quarters > 0 > income Statement > net Income
395820648.68
Quarters > 0 > income Statement > eps
0.22259680845839494
Quarters > 0 > income Statement > dividends Per Share
45931616.8
Quarters > 0 > income Statement > shares Outstanding
1778195525
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
15.749262008884566
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
CNY
Quarters > 0 > balance Sheet > cash
1301728328.16
Quarters > 0 > balance Sheet > short Term Investments
859819591.42
Quarters > 0 > balance Sheet > receivables
2544688491.63
Quarters > 0 > balance Sheet > inventories
1305149095.05
Quarters > 0 > balance Sheet > total Current Assets
7593140091.62
Quarters > 0 > balance Sheet > property Plant Equipment
11166626715.47
Quarters > 0 > balance Sheet > total Assets
25197008155.37
Quarters > 0 > balance Sheet > payables
527832654.3
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
4209325766.81
Quarters > 0 > balance Sheet > total Liabilities
10327954797.3
Quarters > 0 > balance Sheet > equity
14265949611.81
Quarters > 0 > balance Sheet > currency_symbol
CNY
Quarters > 0 > cash Flow > net Income
395820650
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
598427205.45
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
34493942.86
Quarters > 0 > cash Flow > currency_symbol
CNY
Quarters > 0 > ratios > PE
0.22259680845839494
Quarters > 0 > ratios > PB
0.2405670464732963
Quarters > 0 > ratios > ROE
2.774583252083841
Quarters > 0 > ratios > ROA
1.5709033637616319
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
56
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
3098813569.89
Quarters > 1 > income Statement > cost Of Revenue
2055900744.63
Quarters > 1 > income Statement > gross Profit
1042912825.26
Quarters > 1 > income Statement > operating Expenses
2653292771.06
Quarters > 1 > income Statement > operating Income
445520798.83
Quarters > 1 > income Statement > interest Expense
43875941.36
Quarters > 1 > income Statement > pretax Income
363586770.93
Quarters > 1 > income Statement > net Income
305575186.04
Quarters > 1 > income Statement > eps
0.17188524630806679
Quarters > 1 > income Statement > dividends Per Share
-40651616.9
Quarters > 1 > income Statement > shares Outstanding
1777786009
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
14.377141082605199
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
CNY
Quarters > 1 > balance Sheet > cash
1262763166.96
Quarters > 1 > balance Sheet > short Term Investments
1415227978.99
Quarters > 1 > balance Sheet > receivables
2281492955.73
Quarters > 1 > balance Sheet > inventories
1166580816.12
Quarters > 1 > balance Sheet > total Current Assets
7384443685.17
Quarters > 1 > balance Sheet > property Plant Equipment
10789503038.28
Quarters > 1 > balance Sheet > total Assets
24332822720.98
Quarters > 1 > balance Sheet > payables
484258018.39
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
4357275040.55
Quarters > 1 > balance Sheet > total Liabilities
9686700206.35
Quarters > 1 > balance Sheet > equity
14042171870.45
Quarters > 1 > balance Sheet > currency_symbol
CNY
Quarters > 1 > cash Flow > net Income
305575186.04
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
555720062.54
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-449382569.99
Quarters > 1 > cash Flow > currency_symbol
CNY
Quarters > 1 > ratios > PE
0.17188524630806679
Quarters > 1 > ratios > PB
0.24434446672671617
Quarters > 1 > ratios > ROE
2.1761248107427376
Quarters > 1 > ratios > ROA
1.2558147878853778
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
55
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
3458499823.03
Quarters > 2 > income Statement > cost Of Revenue
2241774162.27
Quarters > 2 > income Statement > gross Profit
1216725660.76
Quarters > 2 > income Statement > operating Expenses
2813423590.55
Quarters > 2 > income Statement > operating Income
645076232.48
Quarters > 2 > income Statement > interest Expense
50295988.02
Quarters > 2 > income Statement > pretax Income
469387973.69
Quarters > 2 > income Statement > net Income
371551701.87
Quarters > 2 > income Statement > eps
0.20899686463332945
Quarters > 2 > income Statement > dividends Per Share
43097478.04
Quarters > 2 > income Statement > shares Outstanding
1777786009
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
18.651908789599045
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
CNY
Quarters > 2 > balance Sheet > cash
1689916082.15
Quarters > 2 > balance Sheet > short Term Investments
1115264752.63
Quarters > 2 > balance Sheet > receivables
2409025783.46
Quarters > 2 > balance Sheet > inventories
1116665159.58
Quarters > 2 > balance Sheet > total Current Assets
7608179522.72
Quarters > 2 > balance Sheet > property Plant Equipment
10622558600.82
Quarters > 2 > balance Sheet > total Assets
23927398321.23
Quarters > 2 > balance Sheet > payables
477089050.2
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
4377367879.56
Quarters > 2 > balance Sheet > total Liabilities
9704526037.38
Quarters > 2 > balance Sheet > equity
13619333910
Quarters > 2 > balance Sheet > currency_symbol
CNY
Quarters > 2 > cash Flow > net Income
371551700
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
541557182.99
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-308581726.95
Quarters > 2 > cash Flow > currency_symbol
CNY
Quarters > 2 > ratios > PE
0.20899686463332945
Quarters > 2 > ratios > PB
0.25193060248348076
Quarters > 2 > ratios > ROE
2.728119483120889
Quarters > 2 > ratios > ROA
1.5528295090082331
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
56
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
3212811697.13
Quarters > 3 > income Statement > cost Of Revenue
2097584717.92
Quarters > 3 > income Statement > gross Profit
1115226979.21
Quarters > 3 > income Statement > operating Expenses
2700530556.68
Quarters > 3 > income Statement > operating Income
512281140.45
Quarters > 3 > income Statement > interest Expense
55167957.39
Quarters > 3 > income Statement > pretax Income
395024473.61
Quarters > 3 > income Statement > net Income
308396080.13
Quarters > 3 > income Statement > eps
0.17253947864084518
Quarters > 3 > income Statement > dividends Per Share
109631264.23
Quarters > 3 > income Statement > shares Outstanding
1787394297
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
15.944947564391027
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
CNY
Quarters > 3 > balance Sheet > cash
2001124529.33
Quarters > 3 > balance Sheet > short Term Investments
596881920.76
Quarters > 3 > balance Sheet > receivables
2271110194.18
Quarters > 3 > balance Sheet > inventories
1195752161.5
Quarters > 3 > balance Sheet > total Current Assets
7097859355.14
Quarters > 3 > balance Sheet > property Plant Equipment
10381702773.99
Quarters > 3 > balance Sheet > total Assets
23570041501.34
Quarters > 3 > balance Sheet > payables
485586643.07
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
4330224099.54
Quarters > 3 > balance Sheet > total Liabilities
9543999010.21
Quarters > 3 > balance Sheet > equity
13387169858.4
Quarters > 3 > balance Sheet > currency_symbol
CNY
Quarters > 3 > cash Flow > net Income
308396080
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
548871755.43
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-351266949.28
Quarters > 3 > cash Flow > currency_symbol
CNY
Quarters > 3 > ratios > PE
0.17253947864084518
Quarters > 3 > ratios > PB
0.25768486018315867
Quarters > 3 > ratios > ROE
2.3036689859917763
Quarters > 3 > ratios > ROA
1.3084240013428365
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
55
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
12275774875.03
Annuals > 0 > income Statement > cost Of Revenue
8072643718.49
Annuals > 0 > income Statement > gross Profit
4203131156.54
Annuals > 0 > income Statement > operating Expenses
10411399264.83
Annuals > 0 > income Statement > operating Income
1864375610.2
Annuals > 0 > income Statement > interest Expense
243717746.62
Annuals > 0 > income Statement > pretax Income
2091263494.15
Annuals > 0 > income Statement > net Income
1793350814.5
Annuals > 0 > income Statement > eps
1.0087551625568
Annuals > 0 > income Statement > dividends Per Share
-542234338.9
Annuals > 0 > income Statement > shares Outstanding
1777786009
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
15.187437283428054
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
CNY
Annuals > 0 > balance Sheet > cash
1689916082.15
Annuals > 0 > balance Sheet > short Term Investments
1115264752.63
Annuals > 0 > balance Sheet > receivables
2409025783.46
Annuals > 0 > balance Sheet > inventories
1116665159.58
Annuals > 0 > balance Sheet > total Current Assets
7608179522.72
Annuals > 0 > balance Sheet > property Plant Equipment
10622558600.82
Annuals > 0 > balance Sheet > total Assets
23927398321.23
Annuals > 0 > balance Sheet > payables
477089050.2
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
4377367879.56
Annuals > 0 > balance Sheet > total Liabilities
9704526037.38
Annuals > 0 > balance Sheet > equity
13619333910
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
1793350814.5
Annuals > 0 > cash Flow > depreciation
1048667038.59
Annuals > 0 > cash Flow > change In Working Capital
-150523207.64
Annuals > 0 > cash Flow > cash From Operations
2576656397.08
Annuals > 0 > cash Flow > capital Expenditures
2040641185.79
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-4166152835.35
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
1.0087551625568
Annuals > 0 > ratios > PB
0.25193060248348076
Annuals > 0 > ratios > ROE
13.167683723381154
Annuals > 0 > ratios > ROA
7.494967862464254
Annuals > 0 > ratios > FCF
536015211.28999996
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.04366447061360679
Annuals > 0 > health Score
66
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
11537996314.78
Annuals > 1 > income Statement > cost Of Revenue
7413512033.14
Annuals > 1 > income Statement > gross Profit
4124484281.64
Annuals > 1 > income Statement > operating Expenses
9704667269.11
Annuals > 1 > income Statement > operating Income
1833329045.67
Annuals > 1 > income Statement > interest Expense
182191955.06
Annuals > 1 > income Statement > pretax Income
1837886586.23
Annuals > 1 > income Statement > net Income
1601096033.08
Annuals > 1 > income Statement > eps
0.8961029681467554
Annuals > 1 > income Statement > dividends Per Share
444791842.94
Annuals > 1 > income Statement > shares Outstanding
1786732206
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
15.889492383712525
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
5918915276.72
Annuals > 1 > balance Sheet > short Term Investments
621983351.26
Annuals > 1 > balance Sheet > receivables
2242025579.78
Annuals > 1 > balance Sheet > inventories
1013079365.83
Annuals > 1 > balance Sheet > total Current Assets
10874413206.01
Annuals > 1 > balance Sheet > property Plant Equipment
9904810355.45
Annuals > 1 > balance Sheet > total Assets
26476712835.6
Annuals > 1 > balance Sheet > payables
412220642.83
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
8199665106.58
Annuals > 1 > balance Sheet > total Liabilities
13238666497.83
Annuals > 1 > balance Sheet > equity
12556797361.42
Annuals > 1 > balance Sheet > currency_symbol
CNY
Annuals > 1 > cash Flow > net Income
1601096030
Annuals > 1 > cash Flow > depreciation
927170617.87
Annuals > 1 > cash Flow > change In Working Capital
34551.34
Annuals > 1 > cash Flow > cash From Operations
2753538934.89
Annuals > 1 > cash Flow > capital Expenditures
2865320812.38
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
4429401928.89
Annuals > 1 > cash Flow > currency_symbol
CNY
Annuals > 1 > ratios > PE
0.8961029681467554
Annuals > 1 > ratios > PB
0.27462362084260267
Annuals > 1 > ratios > ROE
12.750831179288364
Annuals > 1 > ratios > ROA
6.047185853552039
Annuals > 1 > ratios > FCF
-111781877.49000025
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
-0.009688153336191427
Annuals > 1 > health Score
56
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
10266288179.53
Annuals > 2 > income Statement > cost Of Revenue
6497890211.79
Annuals > 2 > income Statement > gross Profit
3768397967.74
Annuals > 2 > income Statement > operating Expenses
8515702383.78
Annuals > 2 > income Statement > operating Income
1750585795.75
Annuals > 2 > income Statement > interest Expense
167311559.61
Annuals > 2 > income Statement > pretax Income
1666391305.45
Annuals > 2 > income Statement > net Income
1374604224.18
Annuals > 2 > income Statement > eps
0.7693961233300091
Annuals > 2 > income Statement > dividends Per Share
404761140.31
Annuals > 2 > income Statement > shares Outstanding
1786601443
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
17.05178897316073
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
CNY
Annuals > 2 > balance Sheet > cash
1497483832.74
Annuals > 2 > balance Sheet > short Term Investments
745362386.95
Annuals > 2 > balance Sheet > receivables
1881882496.4
Annuals > 2 > balance Sheet > inventories
1041461328.57
Annuals > 2 > balance Sheet > total Current Assets
6536006646.99
Annuals > 2 > balance Sheet > property Plant Equipment
8285750175.47
Annuals > 2 > balance Sheet > total Assets
20492557228.07
Annuals > 2 > balance Sheet > payables
406347908.05
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
4454261021.3
Annuals > 2 > balance Sheet > total Liabilities
9652689512.9
Annuals > 2 > balance Sheet > equity
10548615357.2
Annuals > 2 > balance Sheet > currency_symbol
CNY
Annuals > 2 > cash Flow > net Income
1374604000
Annuals > 2 > cash Flow > depreciation
696179837.44
Annuals > 2 > cash Flow > change In Working Capital
-346465096.06
Annuals > 2 > cash Flow > cash From Operations
2142816416.93
Annuals > 2 > cash Flow > capital Expenditures
2949861151.85
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
-1409996718.41
Annuals > 2 > cash Flow > currency_symbol
CNY
Annuals > 2 > ratios > PE
0.7693961233300091
Annuals > 2 > ratios > PB
0.3268808908305162
Annuals > 2 > ratios > ROE
13.031134207028966
Annuals > 2 > ratios > ROA
6.70782181492271
Annuals > 2 > ratios > FCF
-807044734.9199998
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
-0.07861115145093726
Annuals > 2 > health Score
63
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
7443769724.38
Annuals > 3 > income Statement > cost Of Revenue
4764854017.33
Annuals > 3 > income Statement > gross Profit
2678915707.05
Annuals > 3 > income Statement > operating Expenses
5918912078.52
Annuals > 3 > income Statement > operating Income
1524857645.86
Annuals > 3 > income Statement > interest Expense
83073479.64
Annuals > 3 > income Statement > pretax Income
1910995517.08
Annuals > 3 > income Statement > net Income
1661028567.53
Annuals > 3 > income Statement > eps
0.9295595667111406
Annuals > 3 > income Statement > dividends Per Share
284715217.06
Annuals > 3 > income Statement > shares Outstanding
1786898470
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
20.485019047079764
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
CNY
Annuals > 3 > balance Sheet > cash
3543819700.44
Annuals > 3 > balance Sheet > short Term Investments
1554621127.96
Annuals > 3 > balance Sheet > receivables
1228848978.96
Annuals > 3 > balance Sheet > inventories
680039960.57
Annuals > 3 > balance Sheet > total Current Assets
8643502127.97
Annuals > 3 > balance Sheet > property Plant Equipment
5667330682.66
Annuals > 3 > balance Sheet > total Assets
18389124353.35
Annuals > 3 > balance Sheet > payables
315533528.16
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
4423185058.36
Annuals > 3 > balance Sheet > total Liabilities
8093817609.58
Annuals > 3 > balance Sheet > equity
10129240934.77
Annuals > 3 > balance Sheet > currency_symbol
CNY
Annuals > 3 > cash Flow > net Income
1661028600
Annuals > 3 > cash Flow > depreciation
497920432.85
Annuals > 3 > cash Flow > change In Working Capital
130039063.11
Annuals > 3 > cash Flow > cash From Operations
2058043830.38
Annuals > 3 > cash Flow > capital Expenditures
2092821567.79
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
415775619.09
Annuals > 3 > cash Flow > currency_symbol
CNY
Annuals > 3 > ratios > PE
0.9295595667111406
Annuals > 3 > ratios > PB
0.34047112407621966
Annuals > 3 > ratios > ROE
16.39835184320962
Annuals > 3 > ratios > ROA
9.032668090187805
Annuals > 3 > ratios > FCF
-34777737.40999985
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
-0.004672059816156729
Annuals > 3 > health Score
68
Valuation > metrics > PE
16.0833
Valuation > metrics > PB
0.2405670464732963
Valuation > final Score
100
Valuation > verdict
38.0% Undervalued
Profitability > metrics > ROE
2.774583252083841
Profitability > metrics > ROA
5.2128716697435715
Profitability > metrics > Net Margin
0.11843339235130408
Profitability > final Score
39
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.7239584520016845
Risk > metrics > Interest Coverage
10.465544229576125
Risk > final Score
88
Risk > verdict
Low
Liquidity > metrics > Current Ratio
14.38550652325566
Liquidity > metrics > Quick Ratio
11.912849546811374
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
90
Prev Valuations > 2
90
Prev Profitabilities > 0
32
Prev Profitabilities > 1
36
Prev Profitabilities > 2
32
Prev Risks > 0
88
Prev Risks > 1
88
Prev Risks > 2
85
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:23:32.723Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
0.33
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-10-28
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.0348
Earnings History > 1 > eps Estimate
0.25
Earnings History > 1 > eps Difference
-0.2152
Earnings History > 1 > surprise Percent
-86.08
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-21
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.031
Earnings History > 2 > eps Estimate
0.23
Earnings History > 2 > eps Difference
-0.199
Earnings History > 2 > surprise Percent
-86.5217
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.0238
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2024-12-31
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0.0291
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-10-29
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
CNY
Earnings History > 5 > eps Actual
0.0241
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-26
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
CNY
Earnings History > 6 > eps Actual
0.0687
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-04-25
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
CNY
Earnings History > 7 > eps Actual
0.018
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2023-12-31
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
CNY
Earnings History > 8 > eps Actual
0.0359
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-09-30
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CNY
Earnings History > 9 > eps Actual
0.0276
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Production Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science and preformulation, formulation development, and analytical development. It also provides clinical research services; macromolecular and cell and gene therapy services comprising drug discovery, development and production services, cell and gene therapy laboratory services, and gene therapy drug development and production services. In addition, the company is involved in the provision of technology development, technology transfer, technical consultation, technical services, and technical training; import and export of goods and technologies. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Pharmaron Beijing Co., Ltd.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
0.33
Date
2025-09-30
EPS Actual
0.0348
EPS Estimate
0.25
EPS Difference
-0.2152
Surprise Percent
-86.08%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.